91 News - TranslationalScience /channels/news_feeds/all/term/TranslationalScience/rss en 91 scientists unveil “Alenomers,” a new molecular platform that could rival antibodies /channels/channels/news/mcgill-scientists-unveil-alenomers-new-molecular-platform-could-rival-antibodies-372852 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><i>Montreal, May 6, 2026</i> – Researchers from 91 have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.</p></div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/untitled-2.png?itok=bfOdKXyu" width="160" height="53" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">6 </span><span class="month">May </span><span class="year">2026</span></div></div></div></div></div> Wed, 06 May 2026 13:43:31 +0000 webfull 218027 at /channels